$29.24
0[0.00%]
Last update: 4:01PM Get Real Time Here
Integra Lifesciences
(NASDAQ:IART)Latest News for Integra Lifesciences Stock (NASDAQ:IART)
Integra Lifesciences Stock (NASDAQ: IART)
Categories: All
Friday, April 19, 2024
Wednesday, April 03, 2024
Monday, March 11, 2024
Thursday, March 07, 2024
Friday, March 01, 2024
Thursday, February 29, 2024
Wednesday, February 28, 2024
- Earnings Scheduled For February 28, 2024Benzinga Insights - Feb 28, 2024, 6:24AM
- Integra LifeSciences' Jan De Witte To Retire As President And CEO Following Appointment Of Successor, Which Is Expected To Occur By End Of 2024. The Company Also Appointed Stuart Essig, Integra's Chairman, As Executive Chairman, Effective ImmediatelyBenzinga Newsdesk - Feb 28, 2024, 6:20AM
- Integra LifeSciences Forecasts Q1 Fiscal Year 2024 Adjusted EPS Of $0.53-$0.57. Versus Consensus Of $0.75Benzinga Newsdesk - Feb 28, 2024, 6:10AM
- Integra LifeSciences Forecasts Q1 Fiscal Year 2024 Revenues Of $360M-$365M, Representing Reported Growth Of Approximately -5.5% To -4.1% And Organic Growth Of Approximately -5.1% To -3.7%. Versus Consensus Of $380.91MBenzinga Newsdesk - Feb 28, 2024, 6:10AM
- Integra LifeSciences Forecasts Fiscal Year 2024 Adjusted EPS Of $3.15-$3.25 Versus Consensus Of $3.44Benzinga Newsdesk - Feb 28, 2024, 6:07AM
- Integra LifeSciences Forecasts Fiscal Year 2024 Revenues Of $1.603B-$1.618B, Representing Reported And Organic Growth Of Approximately 4.0%-5.0%, Versus Consensus Of $1.62BBenzinga Newsdesk - Feb 28, 2024, 6:06AM
- Recap: Integra Lifesciences Q4 EarningsBenzinga Insights - Feb 28, 2024, 6:05AM
- Integra Lifesciences Q4 Adjusted EPS $0.89 Misses $0.90 Estimate, Sales $397.04M Miss $399.34M EstimateBenzinga Newsdesk - Feb 28, 2024, 6:03AM
Friday, December 22, 2023
Thursday, December 14, 2023
Wednesday, December 13, 2023
- Neurosurgery Focused Integra LifeSciences Bolsters Its ENT Portfolio With $275M Acquisition DealVandana Singh - Dec 13, 2023, 11:20AM
- Integra LifeSciences Enters Definitive Agreement To Acquire Acclarent From Ethicon, A Johnson & Johnson MedTech Company, For $275M Cash At Closing And Additional $5M MilestonesBenzinga Newsdesk - Dec 13, 2023, 6:18AM
Tuesday, December 05, 2023
- The Latest Analyst Ratings for Integra LifesciencesBenzinga Insights - Dec 5, 2023, 8:00AM
- Block To Rally Around 54%? Here Are 10 Top Analyst Forecasts For TuesdayLisa Levin - Dec 5, 2023, 7:22AM
- Wells Fargo Upgrades Integra Lifesciences to Overweight, Raises Price Target to $49Benzinga Newsdesk - Dec 5, 2023, 6:01AM
Tuesday, November 14, 2023
Thursday, October 26, 2023
Wednesday, October 25, 2023
- Earnings Scheduled For October 25, 2023Benzinga Insights - Oct 25, 2023, 7:32AM
- Integra LifeSciences Revised FY23 Guidance For Revenue To $1.541B-$1.547B (From $1.548B- $1.560B) Vs. Consensus Of $1.55B; Adj. EPS To $3.10 to $3.14 (From $3.10 To $3.18) Vs. Consensus Of $3.14Benzinga Newsdesk - Oct 25, 2023, 6:09AM
- Integra LifeSciences Sees Q4 Revenues Of $397M to $403M Vs. Consensus Of $405.48M; Adjusted EPS Of $0.89 to $0.93 Vs. Consensus Of $0.92Benzinga Newsdesk - Oct 25, 2023, 6:07AM
- Integra Lifesciences Q3 Adj. EPS $0.76 Misses $0.78 Estimate, Sales $382.42M Miss $387.12M EstimateBenzinga Newsdesk - Oct 25, 2023, 6:05AM
Thursday, August 24, 2023
- Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2023Benzinga Insights - Aug 24, 2023, 11:00AM
- The Latest Analyst Ratings for Integra LifesciencesBenzinga Insights - Aug 24, 2023, 9:00AM
- Morgan Stanley Downgrades Integra Lifesciences to Underweight, Announces $44 Price TargetBenzinga Newsdesk - Aug 24, 2023, 5:38AM
Friday, July 28, 2023
Thursday, July 27, 2023
- Integra LifeSciences For 3Q23 Expects Revenues Of $386M-$390M Vs. Consensus Of $388.59M; Adjusted EPS Of $0.76-$0.80 Vs. Consensus Of $0.84Benzinga Newsdesk - Jul 27, 2023, 12:40AM
- Integra LifeSciences Lowers FY23 Guidance, Sees Revenue Of $1.548B- $1.560B (Prior View $1.602B-$1.62B) Vs. Consensus Of $1.56B; Adjusted EPS Of $3.10 To $3.18 (Prior $3.43-$3.51) Vs. Consensus Of $3.12Benzinga Newsdesk - Jul 27, 2023, 12:37AM
- Integra Lifesciences Q2 EPS $0.71 Beats $0.57 Estimate, Sales $381.30M Beat $374.07M EstimateBenzinga Newsdesk - Jul 27, 2023, 12:29AM
Wednesday, July 19, 2023
Wednesday, July 12, 2023
- Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2023Benzinga Insights - Jul 12, 2023, 11:02AM
- The Latest Analyst Ratings for Integra LifesciencesBenzinga Insights - Jul 12, 2023, 8:01AM
- Jefferies Upgrades Integra Lifesciences to Buy, Lowers Price Target to $53Benzinga Newsdesk - Jul 12, 2023, 5:26AM